Class information for:
Level 1: ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16671 577 38.6 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
88 25697 ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES Author keyword 32 80% 3% 20
2 ASCA Author keyword 30 49% 8% 45
3 ANTI SACCHAROMYCES CEREVISIAE ANTIBODY Author keyword 21 75% 3% 15
4 SEROLOGICAL ANTIBODIES Author keyword 11 100% 1% 6
5 PANCA Author keyword 10 40% 3% 19
6 ANTI SACCHAROMYCES CEREVISIAE MANNAN ANTIBODIES Author keyword 6 71% 1% 5
7 PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES Author keyword 5 54% 1% 7
8 ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES ASCA Author keyword 4 67% 1% 4
9 ANTI L Author keyword 4 75% 1% 3
10 ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES Author keyword 3 17% 3% 19

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES 32 80% 3% 20 Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODIES Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODIES
2 ASCA 30 49% 8% 45 Search ASCA Search ASCA
3 ANTI SACCHAROMYCES CEREVISIAE ANTIBODY 21 75% 3% 15 Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODY Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODY
4 SEROLOGICAL ANTIBODIES 11 100% 1% 6 Search SEROLOGICAL+ANTIBODIES Search SEROLOGICAL+ANTIBODIES
5 PANCA 10 40% 3% 19 Search PANCA Search PANCA
6 ANTI SACCHAROMYCES CEREVISIAE MANNAN ANTIBODIES 6 71% 1% 5 Search ANTI+SACCHAROMYCES+CEREVISIAE+MANNAN+ANTIBODIES Search ANTI+SACCHAROMYCES+CEREVISIAE+MANNAN+ANTIBODIES
7 PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES 5 54% 1% 7 Search PERINUCLEAR+ANTINEUTROPHIL+CYTOPLASMIC+ANTIBODIES Search PERINUCLEAR+ANTINEUTROPHIL+CYTOPLASMIC+ANTIBODIES
8 ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES ASCA 4 67% 1% 4 Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODIES+ASCA Search ANTI+SACCHAROMYCES+CEREVISIAE+ANTIBODIES+ASCA
9 ANTI L 4 75% 1% 3 Search ANTI+L Search ANTI+L
10 ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES 3 17% 3% 19 Search ANTI+NEUTROPHIL+CYTOPLASMIC+ANTIBODIES Search ANTI+NEUTROPHIL+CYTOPLASMIC+ANTIBODIES

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MANNAN ANTIBODIES 130 82% 13% 75
2 ANTI SACCHAROMYCES CEREVISIAE 53 52% 13% 73
3 MICROBIAL ANTIGENS 48 56% 10% 59
4 P ANCA 36 55% 8% 45
5 NEUTROPHIL AUTOANTIBODIES 35 64% 6% 34
6 DIAGNOSTIC ROLE 31 58% 6% 35
7 HUNGARIAN IBD COHORT 24 91% 2% 10
8 FAMILIAL EXPRESSION 23 76% 3% 16
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES 20 12% 27% 157
10 SACCHAROMYCES CEREVISIAE ANTIBODIES 19 50% 5% 27

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes 2015 8 86 71%
Serological antibodies in inflammatory bowel disease: A systematic review 2012 36 176 76%
Serologic markers in inflammatory bowel disease 2006 91 70 87%
Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease 2006 71 78 88%
Serologic Antiglycan Antibodies in Inflammatory Bowel Disease 2011 13 49 78%
Diagnosis and classification of Crohn's disease 2014 17 30 23%
Serological markers in inflammatory bowel diseases 2003 43 88 73%
Serological markers of inflammatory bowel disease 2013 4 85 74%
Mycobiota in gastrointestinal diseases 2015 5 78 17%
IBD serological panels: Facts and perspectives 2007 31 64 55%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 U799 2 32% 1.0% 6
2 MT SINAI HOSP IBD GRP 1 100% 0.3% 2
3 PEDIAT IBD 1 19% 0.7% 4
4 U795 1 12% 1.0% 6
5 TRANSPLANTAT IMMUNOL MUCOSAL BIOL 1 10% 1.2% 7
6 351 1 50% 0.2% 1
7 ANIM PATHOL VET MED 1 50% 0.2% 1
8 CELLULAR IMMUNOTHER Y MOL IMMUNODIAGNOST 1 50% 0.2% 1
9 CLIN STUDY INTESTINAL DIS 1 50% 0.2% 1
10 EQUIPE 0360 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000199349 FECAL CALPROTECTIN//CALPROTECTIN//FECAL ALPHA 1 ANTITRYPSIN
2 0.0000199146 NOD2//CARD15//NOD1
3 0.0000138638 ADHERENT INVASIVE E COLI//ADHERENT INVASIVE ESCHERICHIA COLI//JE2526
4 0.0000112264 EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE//MONTREAL CLASSIFICATION//INDETERMINATE COLITIS
5 0.0000103594 DEXTRAN SULFATE SODIUM//EXPERIMENTAL COLITIS//BIOL CHEM BIOACT
6 0.0000098838 PRIMARY SCLEROSING CHOLANGITIS//SCLEROSING CHOLANGITIS//NORWEGIAN PSC
7 0.0000083293 WEGENERS GRANULOMATOSIS//ANCA//MICROSCOPIC POLYANGIITIS
8 0.0000081549 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTE IEL
9 0.0000078502 INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB
10 0.0000068711 RESTORATIVE PROCTOCOLECTOMY//ILEAL POUCH ANAL ANASTOMOSIS//POUCHITIS